XTNT — Xtant Medical Holdings, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1453593 ·
Last close
$0.21
Market Cap
$28.79M
52W High
$0.84
52W Low
$0.17
ADV30
182,941
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 24,285,000 | 13,662,000 | -3,028,000 | -3,562,000 | 75,223,000 | 7,793,000 | 37,964,000 |
| Jun 2026 | 23,031,000 | 13,330,000 | -4,169,000 | -9,413,000 | 79,667,000 | 9,870,000 | 39,652,000 |
| Mar 2026 | 20,884,000 | 11,971,000 | -2,923,000 | -3,089,000 | 78,000,000 | 12,137,000 | 29,401,000 |
| Dec 2025 | 32,357,000 | 17,754,000 | -944,000 | 57,000 | 94,145,000 | 17,053,000 | 43,192,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$570,000
Investing CF
$14,388,000
Financing CF
$-12,030,000
CapEx
$-1,266,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.08
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-266,988,000
Inventory
$33,287,000
Receivables
$19,416,000
ST Investments
—
EBIT TTM
$-6,476,000
Pretax Income TTM
$-9,239,000
Interest Exp TTM
$2,763,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$109,527,000
EBITDA
$-1,473,000
Free Cash Flow
$10,128,750
Enterprise Value
$64,653,576
Total Cash
$9,870,000
Total Debt
$26,012,000
Shares Out
140,287,960
Trailing EPS
$-0.08
Book Value
$0.28
ROE
-25.2%
ROA
-3.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 133,927,000 | 7,284,000 | 4,973,000 | 94,145,000 | 43,192,000 | 50,953,000 | 12,546,000 |
| Dec 2024 | 117,267,000 | -12,074,000 | -16,449,000 | 93,837,000 | 50,874,000 | 42,963,000 | -11,896,000 |
| Dec 2023 | 91,303,000 | -10,158,000 | 660,000 | 92,612,000 | 41,263,000 | 51,349,000 | -9,515,000 |
| Dec 2022 | 57,969,000 | -6,755,000 | -8,485,000 | 60,229,000 | 26,058,000 | 34,171,000 | -5,341,000 |
TTM Snapshot
Revenues TTM
$109,527,000
NetIncome TTM
$-11,137,000
OpCashFlow TTM
—
Assets (Latest)
$79,667,000
Forward EPS
$-0.03
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NSPR | InspireMD, Inc. | $30.45M | $0.65 | — |
| NEPH | NEPHROS INC | $31.52M | $2.90 | — |
| DAVI | DAVION HEALTHCARE PLC | $25.75M | $1.03 | — |
| PLRZ | Polyrizon Ltd. | $25.26M | $10.65 | — |
| MLSS | MILESTONE SCIENTIFIC INC. | $25.10M | $0.28 | — |
News headlines (Yahoo Finance, 1h cache)
Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
2026-11-16 12:00 · Yahoo
Xtant Medical to Announce Third Quarter 2026 Financial Results on November 16, 2026
2026-11-10 13:00 · Yahoo
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...
2026-08-11 21:02 · Yahoo
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-08-04 20:05 · Yahoo
Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped
2026-05-06 12:00 · Yahoo
Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
2026-05-07 12:00 · Yahoo
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
2026-05-14 00:39 · Yahoo
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
2026-05-13 23:01 · Yahoo
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
2026-03-31 19:01 · Yahoo
Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
2026-04-13 13:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.